Cargando…
Five-Year Retention of Perampanel and Polytherapy Patterns: 328 Patients From a Single Center in South Korea
BACKGROUND AND PURPOSE: Perampanel (PER) is an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist used to treat focal and generalized epilepsy. Comprehensive data from real-world settings with long-term follow-ups are still scarce. This study aimed to determine the factors related to PE...
Autores principales: | Park, Kyung-Il, Hwang, Sungeun, Son, Hyoshin, Chu, Kon, Jung, Ki-Young, Lee, Sang Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329921/ https://www.ncbi.nlm.nih.gov/pubmed/37417431 http://dx.doi.org/10.3988/jcn.2022.0338 |
Ejemplares similares
-
Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil
por: Hwang, Sungeun, et al.
Publicado: (2021) -
Lesion Detection Through MRI Postprocessing in Pathology-Proven Focal Cortical Dysplasia: Experience at a Single Institution in the Republic of Korea
por: Son, Hyoshin, et al.
Publicado: (2023) -
Rational Polytherapy with Antiepileptic Drugs
por: Lee, Jong Woo, et al.
Publicado: (2010) -
Polytherapy and drug interactions in elderly
por: Gujjarlamudi, Hima Bindu
Publicado: (2016) -
Association of Zolpidem With Increased Mortality in Patients With Brain Cancer: A Retrospective Cohort Study Based on the National Health Insurance Service Database
por: Hwang, Sungeun, et al.
Publicado: (2022)